公开(公告)号：US20230285562A1

公开(公告)日：2023-09-14

申请号：US18018105

申请日：2021-07-30

Applicant: Rohto Pharmaceutical Co., Ltd.

Inventor： Ozora Kubo ,  Saeko Hayashi ,  Akiko Kita

IPC: A61K47/02 ,  A61K9/00 ,  A61K9/08 ,  A61K31/519 ,  A61K47/12

CPC classification number: A61K47/02 ,  A61K9/0048 ,  A61K9/08 ,  A61K31/519 ,  A61K47/12

Abstract: The present invention relates to an aqueous composition comprising delgocitinib or a salt thereof (A) and at least one selected from the group consisting of citric acid, phosphoric acid, and a salt thereof (B).

公开(公告)号：US20230285564A1

公开(公告)日：2023-09-14

申请号：US18018108

申请日：2021-07-30

Applicant: Rohto Pharmaceutical Co., Ltd.

Inventor： Ozora Kubo ,  Saeko Hayashi ,  Akiko Kita

IPC: A61K47/22 ,  A61K9/00 ,  A61K9/08 ,  A61K47/18 ,  A61K31/519

CPC classification number: A61K47/22 ,  A61K9/0048 ,  A61K9/08 ,  A61K47/183 ,  A61K31/519

Abstract: The present invention relates to an aqueous composition comprising delgocitinib or a salt thereof (A) and at least one selected from the group consisting of edetic acid, creatinine, and a salt thereof (B).

公开(公告)号：US20230101139A1

公开(公告)日：2023-03-30

申请号：US17788378

申请日：2020-12-25

Applicant: Rohto Pharmaceutical Co., Ltd.

Inventor： Akinori Nishimoto ,  Akiko Kita ,  Saeko Hayashi

IPC: A61K31/519 ,  A61K9/08

Abstract: The present invention relates to an aqueous composition comprising delgocitinib or a salt thereof and having a pH of 4.0 to 6.5.